Cue Biopharma, Inc. (CUE) Reports Q3 Loss, Tops Revenue Estimates

Cue Biopharma, Inc. (CUE) came out with a quarterly loss of $0.17 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.24 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 15%. A quarter ago, it was expected that this company would post a loss of $0.29 per share when it actually produced a loss of $0.20, delivering a surprise of 31.03%.Over the last four quarters, the company has surpasse ...